订阅小程序
旧版功能

Abstract C008: Tolerability and Antitumor Activity of Paclitaxel is Improved by the Addition of Nilotinib in Patients with Refractory Solid Tumors

MOLECULAR CANCER THERAPEUTICS(2019)

引用 0|浏览84
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要